Schema-Root.org logo

 

  cross-referenced news and research resources about

 breast cancers

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Sun. April 15, 2018

-
ROANOKE, Va. - Runners came to Roanoke Saturday to help raise money and awareness for breast cancer in the annual Race for the Cure. See the video above for more. Copyright 2018 by WSLS 10 - All rights reserved. Get email alerts for local stories and events around the world. Sign Up. Powered ...
In many cancer types -- especially in the case of breast cancer -- surgery is often preferred when it comes to removing primary tumors. However, the recurrence of cancer after surgery is not an uncommon occurrence. Some who have gone through surgery are at an increased risk of early ...

The use of postmasstectomy radiation has historically been a controversial topic in patients with 1 to 3 positive lymph nodes, according to Laura M. Freedman, MD. Revisions to the National Comprehensive Cancer Network (NCCN) guidelines have, however, have now allowed physicians to pinpoint ...
More encouragingly, updated results of the SOFT trial demonstrated that the addition of ovarian suppression in the adjuvant setting benefited patients with premenopausal breast cancer. Likewise, the TEXT trial found that the use of adjuvant exemestane plus ovarian suppression resulted in a ...
There are multiple therapeutic options in development for the treatment of patients with HER2-positive breast cancer, further adding to the regimens ... in heavily pretreated patients with HER2-expressing metastatic breast cancers who previously received ado-trastuzumab emtansine (T-DM1; Kadcyla).

At 47, I was a decade and a half younger than the median age for breast cancer diagnosis in the United States. Was this just bad luck? Maybe, but the journalist in me was still curious to know: Why me? So I dug into the literature on risk factors to see where I might have fit in. It's an impossible question to answer ...
Abemaciclib (Verzenio) joined palbociclib (Ibrance) and ribociclib (Kisqali) as the third CDK 4/6 inhibitor for patients with hormone receptor (HR)-positive, HER2-negative breast cancer. Most recently, abemaciclib was approved by the FDA in February 2018 for use in the frontline setting in combination ...
The European Medicines Agency has agreed to review an application by AstraZeneca and MSD requesting the approval of Lynparza (olaparib) for the treatment of patients with a difficult-to-treat type of metastatic breast cancer who previously received chemotherapy. The Marketing Authorization ...
Susan Domchek, MD, director of the Basser Center for BRCA at Penn Medicine, discusses areas of investigation in breast cancer. Things that physicians are looking at as predictors of response to chemotherapy include how many tumor infiltrating lymphocytes (TILs) are at baseline and what the immune ...
The study provides evidence of the potential importance of establishing a minimum recall rate for breast cancer screening programs, the researchers say. Calling women back for additional testing after suspicious mammography findings helps safeguard against missing invasive breast cancers, but carries ...
Scientists have identified a molecule that connects a biochemical pathway used by cancer cells to generate energy and regulates an oncogene that drives the progression of breast cancer and other tumor types. The studies, by a team at Baylor College of Medicine and Roswell Park Comprehensive Cancer ...
MSD and AstraZeneca's Lynparza will be the first PARP inhibitor to be reviewed in Europe for the treatment of breast cancer, after the European Medicines Agency validated the drug's marketing application in this setting. The companies are seeking permission to market the drug for use in patients with ...
Researchers from New Mexico, Massachusetts, Pennsylvania, Washington, New Hampshire, North Carolina, and California, performed a prospective cohort study to determine how often MR imaging was used for breast cancer screening among women who do and do not meet professional society ...
The Trump administration's Department of Health and Human Services (HHS) erased important information on breast cancer screenings and Affordable Care Act (aka Obamacare) benefits related to breast cancer from its women's health website with no warning, according to a report by the transparency ...
OlympiAD included 302 patients with HER2-negative metastatic breast cancer who harbored germline BRCA1 or BRCA2 mutations. Patients were recruited in 19 countries across Europe, Asia, North America, and South America, and received up to 2 prior lines of chemotherapy in the metastatic setting.
During the 5 year screening period, 666 invasive breast cancers were diagnosed in the mammography arm and 524 in the control arm. Of those, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period, a non-significance difference ...

Estrogen levels are 15% higher on average in women with postmenopausal breast cancer, and the cancer risk is doubled at the highest levels, especially in those with both estrogen and progesterone receptors. Any increase in mean serum estrogens is associated with a higher risk of breast cancer ...
RICHMOND, Va. -- There is a new one-stop shop for breast cancer patients at Massey Cancer Center at Stony Point. The Breast Cancer Collaborative Care Clinic opened for women newly diagnosed with breast cancer. "Seems like it reduced some of the stress and anxiety to be able to have every single ...
Misconceptions and fears that many breast cancer patients facing radiation therapy have are typically not realized because of modern techniques, researchers report. Indeed, an overwhelming majority of patients surveyed for this study — comparing pretreatment beliefs with experiences — agreed that ...
The Food and Drug Administration for the first time has authorized a genetic testing company to offer screenings for three breast cancer mutations common in Ashkenazi Jews, giving consumers the ability to initiate testing at home and see results without talking to a doctor or counselor. The agency's action ...
Cancer Net Japan, a Tokyo-based nonprofit organization, recently organized an event to bring together male patients being treated for breast cancer and generate greater public understanding of the disease. In 2015, more than 87,000 people were newly diagnosed with breast cancer in Japan. Less than 1 ...
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers. Their findings were published in the March issue of Health Affairs. Using Medicare ...
She was diagnosed with Stage 2b HER2-positive breast cancer in 2010. Website: www.feliciamitchell.net. A lump in the breast! It can be daunting, even if it turns out to be benign. A fibroadenoma, for example, is a lump of glandular and connective tissue with little or no risk of becoming cancerous. I was first ...
Dr. Gertraud Maskarinec, a preventive medicine physician and nutritional epidemiologist at the University of Hawaii Cancer Center, says that while there isn't a so-called "best diet" for preventing or dealing with breast cancer, avoiding obesity is important. "In terms of breast cancer and what we know about ...
“So, while our treatments have improved over the years, unfortunately, we still know that we have a lot of locally advanced breast cancer where women are presenting with large lumps which they can already feel or which their doctors have found upon examination. It is these women who do not do well with ...
A Mexican company, Higia Technologies, recently launched a new bra that detects breast cancer. They call it Eva and it promises to revolutionize the fashion market by linking it to health. Eva has two patches with biosensors placed in a radial pattern around the user's breasts. Cancerous tumors can cause ...
Engineering researchers at the University of Arkansas have moved closer to developing an alternative method of detecting and possibly treating breast cancer. The researchers, led by Magda El-Shenawee, professor of electrical engineering, work with pulsed, terahertz imaging, a type of electromagnetic ...
In March 2017, the U.S. Food and Drug Administration approved palbociclib for metastatic breast cancer in postmenopausal women in conjunction with Letrozole. Pfizer manufactures the drug under the brand name Ibrance. In November 2017, the National Health Service (NHS) of England approved the ...
Breast cancer spreads to other organs in the body according to certain specific patterns. This has been shown by a team of researchers from Karolinska Institutet and KTH in Sweden and the University of Helsinki in Finland who have mapped breast cancer's spread routes in patients by studying the cancer ...
Their work, published this month in the journal The Lancet Oncology, has led to the identification of the earliest known pictorial depictions of breast cancer. Signs of the disease were found in the oil panel transposition of Michelangelo's statue The Night, painted by Michele di Rodolfo del Ghirlandaio (also ...
Patricia Cook, head of Union County Elementary School in Georgia, was diagnosed with breast cancer in 2017. Student Jayden Rogers, 11, was one of ... Interested in Breast Cancer? Add Breast Cancer as an interest to stay up to date on the latest Breast Cancer news, video, and analysis from ABC News.
Women and their doctors need a greater understanding of the risks of cancer in dense breasts, an MP has warned. A woman with dense breasts - those with more glandular tissue - could be six times more likely to develop breast cancer. At the same time, it can also be harder to detect tumours in dense ...
However, in the largest study of its kind so far, scientists have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population. Good risk management in the hospitals as well as control screenings ...
... the ACR/SBI reclassification of African-American women, including statistics such as African-American women are 42 percent more likely to die from breast cancer than non-Hispanic white women despite comparable incidence rates, and black women have twice the risk of triple-negative breast ...
Once the mice had been inoculated (or not, in the case of the control group), the study authors transplanted breast cancer cells into them and waited to see if the iPS cells had taught their bodies to put up a fight. When combined with the immunity-boosting adjuvant, the iPS vaccination shrunk tumors in ...
“1 in 8 women get breast cancer. Today, I'm the one,” she wrote. “The good news is that I have the most glorious group of supportive and caring family and friends, and fantastic insurance through my union. The bad news is that not all women are so lucky, so let's fight all cancers and make universal health ...
A big breakthrough in the battle against breast cancer may have been found in Connecticut. The discovery was make by a local researcher and helped by a grant from the Terri Brodeur Breast Cancer Foundation with money raised by the Southern Connecticut Breast Cancer Walk. It starts with hundreds of ...
The analysis, published in JAMA Oncology, funded by Cancer Research UK and involving co-authors at the Institute of Cancer Research, compares four common prognostic tests for breast cancer, and finds that not all are able to accurately predict whether the cancer will return after five years. This could be ...
Jennifer Sims-Mourtada, PhD, director of translational breast cancer research at Helen F. Graham Cancer Center & Research Institute, and Adam Marsh, PhD, ... Q: Does the test have the potential to truly distinguish between invasive breast cancers and those that may never spread or pose a threat?
Several markers of bone formation and resorption were found to be predictive of bone-specific recurrence in patients with early breast cancer, according to a new study. “Bone metastases ultimately affect more than two-thirds of patients with advanced disease,” wrote study authors led by Janet E. Brown, ...
FAIRBANKS — The Breast Cancer Detection Center is changing its 1980s-era lobby with help from donors, including Alaska's biggest charitable contributor, the Rasmuson Foundation. The foundation handed off a ceremonial over-sized check for $300,000 to the detection center on Wednesday.
Research shows that black women are more likely to die from breast cancer than white women. The reason women aren't getting treatment after their breast cancer diagnosis, and the emotional impact on families, Thursday at 5 p.m. on Channel 2 Action News.
O'Riordan had done just that many times before, in her career as a breast-cancer surgeon. But this case was different. It would be the first operation she would do after having been treated for breast cancer herself. It would be the first time she donned a surgical mask, after years in a patient's shoes.
Following on from this discovery, Dr. Jeselsohn and her colleagues analyzed these mutations using laboratory models of ER-positive breast cancer, noting that they supported the cancer's resistance to the drugs tamoxifen and fulvestrant. The new study revealed additional mechanisms that researchers had ...
The scientists say the mechanism explains why breast cancers with mutations in the ER gene itself—the target of drugs such as aromatase inhibitors and tamoxifen—become resistant to these therapies and are prone to become metastatic. Resistance to therapy for ER-positive breast cancer is a common ...
Columbia University researchers have used red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment, according to the team. Results from a first pilot ...
A mum from West Norfolk is planning to climb Mount Kilimanjaro to say a fundraising thank-you to those who helped her through breast cancer. ... While breast cancer survival rates are improving, it's normally the spread to other organs, rather than the original tumour, which can prove fatal. But now a ...
Helen had a double mastectomy 20 years ago – but unfortunately, the cancer has returned and spread to her bones. And she's been taking part in a powerful photo series in a bid to show the realities of battling breast cancer. Helen, from Sydney, has been baring her scars alongside her 52-year-old ...
Research suggests they can stop tumours spreading to the bones when they are given to women in the early stages of breast cancer. But scientists in Seattle, US, found they also cut the risk of dying from a breast tumour by 60 per cent. Previous studies have hinted the cheap pills could protect women with ...


 

news and opinion


 


 


 


 


schema-root.org

   human
    diseases
     cancer
       breast

cancers:
       brain
       breast
       cervix
       colon
       lung
       lymphoma
       oral
       radiogenic
       skin